In another sample of 3800 patients with lung cancer, HER2/neu was positive in only 1.7% of patients (N = 65), all of which had adenocarcinoma and were mainly women, non‐smoker and 50% at Stage IV.12 This evidence concerns the gene ERBB2 and adenocarcinoma.